G.F. Samelis

503 total citations
23 papers, 372 citations indexed

About

G.F. Samelis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, G.F. Samelis has authored 23 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in G.F. Samelis's work include Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). G.F. Samelis is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). G.F. Samelis collaborates with scholars based in Greece, Cyprus and Netherlands. G.F. Samelis's co-authors include Konstantinos Ekmektzoglou, Theodoros Xanthos, Pavlos Papakostas, Dimosthenis Skarlos, Gerasimos Aravantinos, George Fountzilas, Gonzalo Rubio, J van Ark-Otte, Giuseppe Giaccone and Meletios Α. Dimopoulos and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

G.F. Samelis

23 papers receiving 352 citations

Peers

Countries citing papers authored by G.F. Samelis

Since Specialization

Citations

This map shows the geographic impact of G.F. Samelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.F. Samelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.F. Samelis more than expected).

Fields of papers citing papers by G.F. Samelis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.F. Samelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.F. Samelis. The network helps show where G.F. Samelis may publish in the future.

Co-authorship network of co-authors of G.F. Samelis

This figure shows the co-authorship network connecting the top 25 collaborators of G.F. Samelis. A scholar is included among the top collaborators of G.F. Samelis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.F. Samelis. G.F. Samelis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Multicenter, Prospective, Observational Study to Assess the Clinical Activity and Impact on Symptom Burden and Patients’ Quality of Life in Patients with Advanced Soft Tissue Sarcomas Treated with Trabectedin in a Real-World Setting in Greece 2022 ·Cancers ·Stefania Kokkali, I. Boukovinas, E. Samantas, Pavlos Papakotoulas, Ilias Athanasiadis, C. Andreadis, (unknown), G.F. Samelis, Eleni Timotheadou, (unknown), Christos Papadimitriou, (unknown), Alexandros Ardavanis, Ioannis Kotsantis, (unknown), (unknown), Amanda Psyrri	3
2	The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study 2021 ·Cancers ·Michalis V. Karamouzis, Ilias Athanasiadis, G.F. Samelis, (unknown), (unknown), (unknown), (unknown), Panagiotis Sarantis, (unknown), Dimitriοs Schizas, Alexandros Papalampros, Evangelos Felekouras, Dimitrios Dimitroulis, (unknown), Georgios C. Sotiropoulos, Pavlos Papakotoulas	15
3	Gastroesophageal junction and gastroesophageal junction carcinoma : a short update. 2017 ·PubMed ·Konstantinos Ekmektzoglou, P. Apostolopoulos, G.F. Samelis, Georgios Alexandrakis	1
4	Genomic instability in ulcerative colitis: a prerequisite for cancer in the inflammatory colon? 2012 ·PubMed ·Konstantinos Ekmektzoglou, G.F. Samelis, Sophia N. Karagiannis, Georgios Zografos, Theodoros Xanthos	2
5	The Continuation of Bevacizumab Following Disease Progression in Patients with Metastatic Colorectal Cancer Offers a Survival Benefit 2011 ·Hepatogastroenterology ·G.F. Samelis, Konstantinos Ekmektzoglou, (unknown), Manousos M. Konstadoulakis	3
6	Survival Benefit with the Combination of Docetaxel, Gemcitabine and Erlotinib in Advanced and/or Metastatic Pancreatic Cancer Patients 2011 ·Hepatogastroenterology ·G.F. Samelis, Konstantinos Ekmektzoglou, (unknown), (unknown), Manoussos M. Konstadoulakis	1
7	Heart and tumors: location, metastasis, clinical manifestations, diagnostic approaches and therapeutic considerations 2008 ·Journal of Cardiovascular Medicine ·Konstantinos Ekmektzoglou, G.F. Samelis, Theodoros Xanthos	72
8	Small-Cell Lung Cancer: An Unusual Therapeutic Approach with More than 10-year Overall Survival. Case Report and Review of the Literature 2008 ·Tumori Journal ·G.F. Samelis, Konstantinos Ekmektzoglou, Theodoros Xanthos, Georgios Zografos	1
9	Survival benefit with erlotinib-based chemotherapy in unoperable recurrent and/or metastatic pancreatic cancer 2008 ·Journal of Clinical Oncology ·G.F. Samelis, A. Tsiakou, (unknown), Konstantinos Ekmektzoglou	2
10	Gastrointestinal stromal tumours: Clinical overview, surgery and recent advances in imatinib mesylate therapy 2006 ·European Journal of Surgical Oncology ·G.F. Samelis, Konstantinos Ekmektzoglou, George Zografos	14
11	Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study 2005 ·Annals of Oncology ·Haralabos P. Kalofonos, Gerasimos Aravantinos, P. Kosmidis, Pavlos Papakostas, Theofanis Economopoulos, Meletios Α. Dimopoulos, Dimosthenis Skarlos, Aristotelis Bamias, Dimitrios Pectasides, (unknown), M. Karina, Αngelos Koutras, Epaminontas Samantas, (unknown), G.F. Samelis, G. Basdanis, F. Kalfarentzos, George Fountzilas	62
12	Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group 2005 ·Annals of Oncology ·Nikolaos I. Xiros, (unknown), Theofanis Economopoulos, G.F. Samelis, (unknown), Efstathios Kastritis, Haralabos P. Kalofonos, (unknown), D. Skarlos, Aristotelis Bamias, Helen Gogas, Dimitrios Bafaloukos, E. Samantas, P. Kosmidis	13
13	The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: A Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group 2005 ·Urology ·G.F. Samelis, Haralabos P. Kalofonos, (unknown), (unknown), Dimosthenis Skarlos, Gerasimos Aravantinos, Christos Kiamouris, (unknown), George Fountzilas, Meletios Α. Dimopoulos	6
14	The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group 2003 ·Urology ·G.F. Samelis, Dimosthenis Skarlos, Dimitrios Bafaloukos, P. Kosmidis, Αchilles Anagnostopoulos, Gerasimos Aravantinos, Meletios Α. Dimopoulos	17
15	Vinblastine and Interferon-Gamma Combination with and without 13-Cis Retinoic Acid for Patients with Advanced Renal Cell Carcinoma 2002 ·Oncology ·(unknown), Meletios Α. Dimopoulos, Haralabos P. Kalofonos, C. Nicolaides, Gerasimos Aravantinos, Dimitrios Bafaloukos, G.F. Samelis, (unknown), Christos Kiamouris, D. Skarlos, Nicholas Pavlidis, (unknown), P. Kosmidis, (unknown)	5
16	First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study 2001 ·European Journal of Cancer ·Pavlos Papakostas, Ch. Kouroussis, N. Androulakis, G.F. Samelis, Gerasimos Aravantinos, Kostas Kalbakis, (unknown), John Souglakos, S. Kakolyris, (unknown)	40
17	Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study 2000 ·Annals of Oncology ·Jim Janinis, Pavlos Papakostas, G.F. Samelis, Dimosthenis Skarlos, (unknown), George Fountzilas	27
18	Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial 1999 ·Cancer Chemotherapy and Pharmacology ·(unknown), Ch. Kouroussis, N. Androulakis, (unknown), S. Kakolyris, G.F. Samelis, E. Papadakis, (unknown), E. Samantas, (unknown), Vassilis Georgoulias	35
19	Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes. 1998 ·Oncology Reports ·J van Ark-Otte, G.F. Samelis, Gonzalo Rubio, (unknown), H. M. Pinedo, Giuseppe Giaccone	9
20	Long term breast cancer treatment with tamoxifen and second primary tumors 1997 ·European Journal of Cancer ·G. Stathopoulos, N. Malamos, G.F. Samelis, Pavlos Papakostas, (unknown), (unknown), Grigorios Xepapadakis	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact